Demographics and clinical data |
Sex | Male | Male | Female | Male | Male | Female |
Age, years | 57 | 52 | 66 | 50 | 65 | 65 |
Smoking status (pack-years) | Past (50) | Past (35) | Past (20) | Past | Past (80) | Past (20) |
mMRC class | 4 | | | | | |
6MWD, m | 250 | | | | | 230 |
EBV target | RML emphysema | RML bulla | RML bulla | RML bulla | RML bulla 15.0×10.1 cm | RML bulla 12.7×10.1 cm |
Pulmonary function tests |
RV, L (% pred) | 8 (340) | 5.37 (215.8) | | | 6.43 (275) | 3.54 (182) |
FVC, L (% pred) | 2.3 (49) | | | | | |
FEV1, L (% pred) | 0.8 (23) | 1.07 (35.4) | 0.71 (38.3) | 0.74 (19.7) | 0.41 (13) | 0.74 (36) |
After EBV procedure |
Follow-up, months | 2 | 6 | 6 | 6 | 2 | 12 |
mMRC class | 2 (+2) | | | | | |
RV, L (gain) | 5.9 (−2.1 L) | | | | 4.74 (−1.69 L) | 2.89 (−0.65 L) |
FVC, L (gain, L and %) | 3.5
(+1.2 L, +52%) | | | | | |
FEV1, L (gain, mL and %) | 1.2
(+400 mL, +50%) | 1.75
(+680 mL, +63%) | 1.03
(+320 mL, +45%) | 0.83
(+90 mL, +12%) | 0.58
(+170 mL, +41%) | 0.86
(+120 mL, +16%) |
6MWD, m (change m and % gain) | 360
(+110 m, 31%) | | | | | 300 (+70 m) |
Outcome | Improved | Improved | Improved | No benefit | Improved | Improved |